Fosun International Ltd0656
▲ ポジティブ資本関連度
Fosun International reported H1 2026 profit attributable to owners surging 160.3% year-on-year to RMB1.72 billion on revenue of RMB86.96 billion.
銘柄への影響 3
Biotech & Genomic Medicine
Fosun International Ltdその他
Shanghai Fosun Pharmaceutical Group Co Ltd600196
± 混在関連度
Fosun Pharma is named only as one of the four core companies contributing 73.5% of group revenue, with no company-specific development.
Shanghai Yuyuan Tourist Mart Co Ltd600655
± 混在関連度
Yuyuan is named only as one of the four core companies contributing 73.5% of group revenue, with no company-specific development.